Lanxess (LXS) Q1 2025(Media) earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025(Media) earnings summary
17 Nov, 2025Executive summary
Q1 2025 sales remained stable at €1,601 million, with EBITDA pre exceptionals rising 32% year-over-year to €133 million, driven by cost savings, improved utilization, and higher volumes despite weak market conditions.
Net income loss narrowed to -€57 million from -€98 million in Q1 2024, supported by better operating performance and Envalior contribution.
Portfolio transformation completed with the divestment of Urethane Systems to UBE Corporation on April 1, 2025, marking exit from the polymer business.
Workforce reduced by approximately 900 employees, achieving cost savings ahead of schedule.
Adjusted EPS improved to €0.23 from -€0.09 year-over-year.
Financial highlights
EBITDA pre margin increased to 8.3% from 6.3% year-over-year.
Gross profit rose to €322 million from €280 million, with gross margin up to 20.1% from 17.4%.
Capex increased 15% to €45 million; cash outflow from operating activities rose to €66 million.
Free cash flow was -€111 million, impacted by seasonal working capital build-up.
Net financial debt increased seasonally to €2,512 million.
Outlook and guidance
Full-year 2025 EBITDA pre exceptionals guidance confirmed at €600–650 million, including Q1 Urethane Systems contribution.
Q2 2025 expected to improve sequentially but remain below prior year due to absence of Urethane Systems contribution.
Guidance marked by uncertainty due to short-term customer order behavior, volatile tariffs, and geopolitical tensions.
Slight growth anticipated in core and consumer businesses; agrochemicals and construction markets remain weak.
Urethane Systems will no longer contribute to earnings following its divestment.
Latest events from Lanxess
- Earnings rose, costs fell, and sustainability advanced amid global uncertainty and strategic refocus.LXS
AGM 20253 Feb 2026 - Q2 2024 EBITDA pre exceptionals surged 69% year-over-year despite lower sales.LXS
Q2 20241 Feb 2026 - EBITDA pre exceptionals jumped 45% and net income returned to profit in Q3 2024.LXS
Q3 202416 Jan 2026 - EBITDA rose 20% in 2024 as cost savings and portfolio focus drove profitability gains.LXS
Q4 202426 Dec 2025 - Q2 sales and EBITDA fell on weak demand, but net debt dropped after Urethane divestment.LXS
Q2 202523 Nov 2025 - EBITDA pre up 32% to €133m; guidance held as Urethane sale supports debt reduction.LXS
Q1 202517 Nov 2025 - Sales and EBITDA fell sharply in Q3 2025, with cost cuts and divestments improving leverage.LXS
Q3 20256 Nov 2025 - Phased exit of JV stake begins, unlocking over €1.2bn in value with EBITDA-linked upside.LXS
Investor Update16 Oct 2025